Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-22-022568

Director bought 735,000 shares at $4.76 ($3,498,600)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fletcher Aaron G.L. Director 2022-03-31 Purchase +735,000 $4.76 $3,498,600 735,000 I: show line 1 in the form
Open-market purchases · 735,000 sh · avg $4.76 · $3,498,600
Loading xslF345X03/doc4.xml…